A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Biostatistics Core Facility Bookmark and Share

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility draws upon a group of statisticians who collaborate in basic, translational, clinical and population research in the City of Hope Comprehensive Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), with additional institutional support.  Its services are available to all City of Hope and Beckman researchers.
 
Areas of expertise include:  Basic science:  statistical methods for assays and bioassays, animal models, genomics (RNA-seq, CHIP-seq, microarray, rRNA microbial classification), mutation spectra, experimental genetics; Translational science:  animal models, xenografts, cell migration, statistics for toxicology, pharmacokinetic modeling; Clinical Science:  clinical trials, diagnostics, biomarkers, retrospective clinical studies, clinical epidemiology; Population Science: Epidemiology, genetic epidemiology; General:  numerical and graphical data summary, statistical inference, and prediction models.
 
Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.

Services

Collaboration in research intended for publication is our main activity.  Contact any core statistician, or contact the director for an introduction (email: #biostat_core).
 
Consulting is available to advise investigators on statistical issues in research, or to explore possible collaboration.  This is often simply a collegial interaction, but investigators may contact the director (email: #biostat_core) for an introduction to a statistician.  Consulting generally consists of one or two meetings, and it’s always free.  Early contact about research planning is always welcomed.
 
Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other clinical and disease characteristics.  (email: #case_finding; phone ext. 32002 or 61444)
 
Statistical Computing is provided in conjunction with collaboration.  The core does not provide user-directed computing, and does not operate a help desk for statistical software.
 
Data extraction from various COH and public databases is provided in conjunction with collaboration, but is not provided as a separate service.
 
To access services or to use the facility, please contact us at 626-256-HOPE (4673), ext. 61444 or via email (#biostat_core or jlongmate@coh.org).
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

Note:  Proposals including a statistician as a collaborator will ordinarily include a biosketch, and possibly a letter of collaboration.  For proposals in which a statistician has a small, defined role, funding for core support may be included as an expense, in which case you may wish to contact the collaborating statistician or the director for a letter of support.  The following generic statement is provided as a resource, but please contact the Biostatistics Core if you use it.
 
The Biostatistics Core is a shared resource of the City of Hope Comprehensive Cancer Center.  It draws upon 10 doctoral-level statisticians and 6 staff statisticians.  Members of the Biostatistics Core collaborate in basic, translational, clinical and population research, and its services are available to all City of Hope researchers.  Research areas supported include: bioassay, animal models, genomics, genetics, mutation, toxicology, pharmacokinetics, diagnostics, biomarkers, clinical trials, clinical epidemiology; population epidemiology, genetic epidemiology.  In general, the core can provide standard and principled approaches to numerical and graphical data summary, statistical inference, modeling, and prediction. Core members help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.  Statistical software includes SAS, R, StatXact, EaST, and NQuery Advisor.  A linux cluster is available for computationally intensive projects, and COH has excellent network and IT support.
 

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. You can request an introduction or consulting appointment by phone (ext 61444) or email (#biostat_core).

Any publication involving the use of core services should arrange for submission of the publication to PubMed Central, in compliance with the NIH Public Access Policy, and should include the following acknowledgement:
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 
It is also generally accepted practice that a collaborating statistician from the core will be included in the authorship list if the research is presented in a public forum or published. Authorship is unrelated to funding.

Pricing

Funding core effort:
 
Consulting refers to one-on-one meetings with Core statisticians to discuss the statistical approaches necessary for the research. Consulting is free, but intended primarily for advice and initial planning discussions.
 
Collaborative projects should fund a statistician’s effort in one of the following ways:
 
Grants:  Include appropriate statistician support in the personnel budget.  
Contracts:  Include appropriate statistician effort in the contract.
Clinical trials: Include appropriate statistician effort in the clinical trials finance budget.
Portfolio studies are those for which a department or investigator has arranged for statistical support from specific core personnel, similar to a grant budget.
Other Studies generally require that statistician effort is supported by the investigator via core charges.
Analysis of Data for Publication – (e.g. a novel or unanticipated statistical need) may be left to the statistician’s discretion and availability.
 
Case finding for Letters of Intent (LOIs) is a free service.  Investigators may use iCode for self-service. Case finding for all other uses may be charged at the published core rates.

Other activities: Occasionally, the Biostatistics Core is asked to assist with data extraction or similar activities that are not a core service, not research, or not collaborative.  If such a request is accepted, it will be billed at full cost-recovery (external) rates. 
 
Hourly Charge Rates:
  CCSG Members Internal Users External Users
Staff Biostatisticians $45.00 $50.00 $89.00
PhD/RSO Statisicians $67.50 $75.00 $136.00

 
 

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Directors

Biostatistics Core Facility

Biostatistics Core Facility

Director: Jeffrey Longmate, Ph.D.
Co-Director: David Smith, Ph.D.

The Biostatistics Core facility draws upon a group of statisticians who collaborate in basic, translational, clinical and population research in the City of Hope Comprehensive Cancer Center. The Core is supported by City of Hope’s NCI-funded Cancer Center Support Grant (CCSG), with additional institutional support.  Its services are available to all City of Hope and Beckman researchers.
 
Areas of expertise include:  Basic science:  statistical methods for assays and bioassays, animal models, genomics (RNA-seq, CHIP-seq, microarray, rRNA microbial classification), mutation spectra, experimental genetics; Translational science:  animal models, xenografts, cell migration, statistics for toxicology, pharmacokinetic modeling; Clinical Science:  clinical trials, diagnostics, biomarkers, retrospective clinical studies, clinical epidemiology; Population Science: Epidemiology, genetic epidemiology; General:  numerical and graphical data summary, statistical inference, and prediction models.
 
Research Roles: Core members can help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.

Services

Collaboration in research intended for publication is our main activity.  Contact any core statistician, or contact the director for an introduction (email: #biostat_core).
 
Consulting is available to advise investigators on statistical issues in research, or to explore possible collaboration.  This is often simply a collegial interaction, but investigators may contact the director (email: #biostat_core) for an introduction to a statistician.  Consulting generally consists of one or two meetings, and it’s always free.  Early contact about research planning is always welcomed.
 
Case finding: The core can provide HIPAA-compliant identification of patients with stored tissue samples or other clinical and disease characteristics.  (email: #case_finding; phone ext. 32002 or 61444)
 
Statistical Computing is provided in conjunction with collaboration.  The core does not provide user-directed computing, and does not operate a help desk for statistical software.
 
Data extraction from various COH and public databases is provided in conjunction with collaboration, but is not provided as a separate service.
 
To access services or to use the facility, please contact us at 626-256-HOPE (4673), ext. 61444 or via email (#biostat_core or jlongmate@coh.org).
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 

Abstract for Grants

Abstract for Grants

Note:  Proposals including a statistician as a collaborator will ordinarily include a biosketch, and possibly a letter of collaboration.  For proposals in which a statistician has a small, defined role, funding for core support may be included as an expense, in which case you may wish to contact the collaborating statistician or the director for a letter of support.  The following generic statement is provided as a resource, but please contact the Biostatistics Core if you use it.
 
The Biostatistics Core is a shared resource of the City of Hope Comprehensive Cancer Center.  It draws upon 10 doctoral-level statisticians and 6 staff statisticians.  Members of the Biostatistics Core collaborate in basic, translational, clinical and population research, and its services are available to all City of Hope researchers.  Research areas supported include: bioassay, animal models, genomics, genetics, mutation, toxicology, pharmacokinetics, diagnostics, biomarkers, clinical trials, clinical epidemiology; population epidemiology, genetic epidemiology.  In general, the core can provide standard and principled approaches to numerical and graphical data summary, statistical inference, modeling, and prediction. Core members help with study design, grant proposals, clinical protocols, data analysis, and manuscripts.  Statistical software includes SAS, R, StatXact, EaST, and NQuery Advisor.  A linux cluster is available for computationally intensive projects, and COH has excellent network and IT support.
 

Using the Facility

Using the Facility

The core encourages collaboration, so investigators are free to contact faculty statisticians directly. You can request an introduction or consulting appointment by phone (ext 61444) or email (#biostat_core).

Any publication involving the use of core services should arrange for submission of the publication to PubMed Central, in compliance with the NIH Public Access Policy, and should include the following acknowledgement:
 
Research reported in this publication included work performed in the Biostatistics Core supported by the National Cancer Institute of the National Institutes of Health under award number P30CA33572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
 
It is also generally accepted practice that a collaborating statistician from the core will be included in the authorship list if the research is presented in a public forum or published. Authorship is unrelated to funding.

Pricing

Pricing

Funding core effort:
 
Consulting refers to one-on-one meetings with Core statisticians to discuss the statistical approaches necessary for the research. Consulting is free, but intended primarily for advice and initial planning discussions.
 
Collaborative projects should fund a statistician’s effort in one of the following ways:
 
Grants:  Include appropriate statistician support in the personnel budget.  
Contracts:  Include appropriate statistician effort in the contract.
Clinical trials: Include appropriate statistician effort in the clinical trials finance budget.
Portfolio studies are those for which a department or investigator has arranged for statistical support from specific core personnel, similar to a grant budget.
Other Studies generally require that statistician effort is supported by the investigator via core charges.
Analysis of Data for Publication – (e.g. a novel or unanticipated statistical need) may be left to the statistician’s discretion and availability.
 
Case finding for Letters of Intent (LOIs) is a free service.  Investigators may use iCode for self-service. Case finding for all other uses may be charged at the published core rates.

Other activities: Occasionally, the Biostatistics Core is asked to assist with data extraction or similar activities that are not a core service, not research, or not collaborative.  If such a request is accepted, it will be billed at full cost-recovery (external) rates. 
 
Hourly Charge Rates:
  CCSG Members Internal Users External Users
Staff Biostatisticians $45.00 $50.00 $89.00
PhD/RSO Statisicians $67.50 $75.00 $136.00

 
 

Contact Us

Biostatistics Core Directors

Jeffrey Longmate, Ph.D.
Director
626-256-HOPE (4673), 62478
jlongmate@coh.org

David Smith, Ph.D.
Co-Director
626-256-HOPE (4673)
dsmith02@coh.org
 
Location
City of Hope and Beckman Research Institute
1500 East Duarte Road
Duarte, CA  91010-3000
 
Information Sciences Building (#171)
Phone:  626-256-HOPE (4673), Ext. 61444
Fax:  626-471-7106 or 626-301-8802
 

Biostatistics Core Facility Directors

Biostatistics Core Directors

Research Shared Services

City of Hope embodies the spirit of scientific collaboration by sharing services and core facilities with colleagues here and around the world.
 

Recognized nationwide for its innovative biomedical research, City of Hope's Beckman Research Institute is home to some of the most tenacious and creative minds in science.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Media Inquiries/Social Media
 
CONNECT WITH US
Facebook  Twitter  YouTube  Blog
 


NEWS & UPDATES
  • “Lucky” is not usually a term used to describe someone diagnosed with cancer.  But that’s how 34-year-old Alex Camargo’s doctor described him when he was diagnosed with thyroid cancer — the disease is one of the most treatable cancers at all stages. That doctor was ultimately proved righ...
  • Geoff Berman, 61, starts his day with the motto: “The sun is up. I’m vertical. It’s a good day.” Ever since he’s been in remission from lymphoma, Berman makes a special point of being grateful for each day, reminding himself that being alive is a gift. “I just enjoy living,” he said. “I give e...
  • Neural stem cells have a natural ability to seek out cancer cells in the brain. Recent research from the laboratories of Michael Barish, Ph.D., and Karen Aboody, M.D., may offer a new explanation for this attraction between stem cells and tumors. Prior to joining City of Hope, Aboody, now a professor in the Dep...
  • The American Society of Clinical Oncology, a group that includes more than 40,000 cancer specialists around the country, recently issued a list of the five most profound cancer advances over the past five decades. Near the top of the list was the introduction of chemotherapy for testicular cancer. To many in th...
  • “The dying, as a group, have been horribly underserved.” So says Bonnie Freeman, R.N., D.N.P., A.N.P.-B.C., A.C.H.P.N., a nurse practitioner in the Department of Supportive Care Medicine at City of Hope. After nearly 25 years, primarily in critical care nursing, Freeman saw that the needs of the dying were ofte...
  • “Are we the only ones who feel this way?” Courtney Bitz, L.C.S.W., a social worker in the Sheri & Les Biller Patient and Family Resource Center at City of Hope, often hears this question from couples trying to cope with a breast cancer diagnosis and still keep their relationship strong. The ques...
  • Diabetes investigators at City of Hope are studying the full trajectory of diabetes and metabolic disorders, as well as complications of the disease. One especially promising approach focuses on proteins known as growth factors. Led by Fouad Kandeel, M.D., Ph.D., chair and professor of the Department of Clinica...
  • Acute myeloid leukemia is the most common form of acute leukemia among adults, accounting for 18,000 diagnoses in 2014. Two decades ago, in 1996, the National Comprehensive Cancer Network (NCCN) published its first guidelines for treatment of acute myeloid leukemia, or AML. Margaret O’Donnell, M.D., assoc...
  • Children diagnosed with cancer are more likely than ever before to survive the disease, but with a potential new set of health problems caused by the cancer treatment itself. Those problems can particularly affect the heart, and as doctors and other health care workers try to assess how best to care for this sp...
  • Karen Reckamp, M.D., M.S., has an office next to my own, and we often see patients at the same time. As such, I’ve gotten to know her quite well over the years, and I’ve also gotten a glimpse of many of her patients. She specializes in lung cancer, and most of her patients have tumors […]
  • Today is National Doctors Day, the official day to recognize, thank and celebrate the tremendous work physicians do each and every day. Launched in 1991 via a presidential proclamation from then-President George Bush, the observance offers a chance to reflect on the qualities that define truly great medical car...
  • When considering cancer risk, categories like “women’s cancers” and “men’s cancers” may not matter. A complete medical history, especially of first-degree relatives, must be considered when evaluating risk. A new study drives home that fact. Published in the journal Cancer, the study found a link between a fami...
  • Precision medicine holds promise – on that doctors, especially cancer specialists, can agree. But this sophisticated approach to treatment, which incorporates knowledge about a person’s genetic profile, environment and lifestyle, isn’t yet standard for all cancers. It can’t be. Researchers and scientists are st...
  • Frank Di Bella, 70, is on a mission: Find a cure for metastatic bladder cancer. It’s just possible he might. Although Di Bella isn’t a world-renowned physician, cancer researcher or scientist, he knows how to make things happen. For more than 20 years, he served as chairman of annual fundraising gal...
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling aplomb. Furt...